October 31, 2020

Volume X, Number 305


October 30, 2020

Subscribe to Latest Legal News and Analysis

October 29, 2020

Subscribe to Latest Legal News and Analysis

Paycheck Protection Program Flexibility Act Signed into Law

Please note that this alert updates and supersedes all prior publications made by our firm  pertaining to the subject matter discussed below.

On June 5, 2020, President Trump signed the Paycheck Protection Program Flexibility Act of 2020 (Flexibility Act) into law.

The Flexibility Act makes a number of changes to the Paycheck Protection Program (PPP) that will impact borrowers, including the following (each of which is qualified in its entirety by the full text of the Flexibility Act):

  • The period during which a borrower may now spend the proceeds of a PPP loan on allowable expenses has been extended until December 31, 2020.

  • The period during which the proceeds used to pay eligible expenses may be forgiven will now end on the earlier of (a) twenty-four weeks following the loan’s origination and (b) December 31, 2020. A borrower that received a PPP loan before the enactment of the Flexibility Act may elect to keep the eight-week covered period.

  • To receive loan forgiveness, a borrower must use at least 60% of the loan proceeds for payroll costs and may use up to 40% for payment of other eligible expenses, namely covered rent obligations, covered utility payments and interest on covered mortgage obligations.

  • A borrower’s forgiveness amount will not be reduced, subject to the other provisions of the CARES Act, on account of a reduced full-time equivalent employee (FTE) count or a reduction in employee salary if the borrower:

    • Can document in good faith that it attempted, but was unable, to rehire individuals who were employees of the borrower on February 15, 2020 and has also been unable to hire similarly qualified employees for unfilled positions on or before December 31, 2020; or

    • Can document in good faith an inability to return to the same level of business activity that existed prior to February 15, 2020 due to compliance  with requirements established or guidance issued by the Secretary of Health and Human Services, the Director of the Centers for Disease Control and Prevention, or the Occupational Safety and Health Administration during the period beginning on March 1, 2020 and ending December 31, 2020, related to the maintenance of standards for sanitation, social distancing, or any other worker or customer safety requirements. 

  • Borrowers who reduced their FTE count and/or salary levels will not be subject to a loan forgiveness reduction if they restore their FTE count and salary levels, as applicable, to the levels required by the CARES Act by December 31, 2020.

  •  Borrowers will now have ten months from the end of the covered period to apply for loan forgiveness.

  • Loan repayment (including payment of principal, interest and fees) will now be deferred until (a) the amount of loan forgiveness has been remitted to the lender by the SBA or (b) ten months after the end of the covered period in the event that the borrower does not apply for loan forgiveness.

  • A borrower that obtains a loan on or after June 5, 2020 will be required to repay the loan over a minimum of five years. Lenders may extend the maturity date of loans entered into prior to June 5, 2020.

  • The payroll tax deferral provision contained in the CARES Act, which was not available to borrowers once they had received notice that their loan was forgiven, is now available to all borrowers.

In addition, the Senate added a letter to the Congressional Record clarifying its intention that the extension of the covered period does not authorize the SBA to issue any new PPP loans after the June 30, 2020 deadline established by the CARES Act.

© Copyright 2020 Sills Cummis & Gross P.C.National Law Review, Volume X, Number 169



About this Author

Brian A. Haskel Corporate Attorney Sills Cummis & Gross New York, NY

Brian A. Haskel is resident in the Sills Cummis & Gross New York office.  He is a highly experienced corporate attorney, with extensive transactional experience in mergers and acquisitions, securities offerings and counseling on general corporate and securities law matters.  Mr. Haskel advises private equity, venture capital and hedge funds, public and private companies and issuers and underwriters, family offices, domestic and foreign clients.  His experience includes joint ventures, reorganizations, debt restructurings, securities law filings, tender and exchange offers, consent...

(212) 500-1541
Alan E. Sherman Tax & Corporate Attorney Sills Cummis & Gross Newark, NJ

Alan E. Sherman focuses on the area of tax and corporate planning. Mr. Sherman regularly counsels clients ranging from small business entrepreneurs to Fortune 500 public companies. He brings a unique advantage to clients — an understanding of business and related areas such as real estate and mergers and acquisitions and the application of the tax laws to achieve the maximum benefit. With this perspective, Mr. Sherman is able to suggest creative and practical tax solutions to client problems. He has extensive experience in the area of taxation of partnerships and limited liability...

(973) 643-5959
Jason L. Sobel Real Estate Attorney Sills Cummis & Gross Newark, NJ

Jason L. Sobel is a Member of the Sills Cummis & Gross Real Estate Department and chairs the Firm’s F.O.R.E. (Family Owned Real Estate) Practice Group.  He primarily counsels retail, industrial, office and residential real estate owners and developers regarding acquisitions, sales, financing, and leasing with respect to their projects.  He also represents several lending institutions in commercial and construction financings as well as a number of clients with respect to retail liquor license transfers and related issues.  Additionally, Mr. Sobel assists different privately-held...

(973) 643-5295
Lori M. Waldron, Sills Cummis Law firm, Emerging Growth Attorney, Stock Acquisition Lawyer

Lori M. Waldron's practice focuses on the representation of both emerging growth and well-established public and private companies in sophisticated business transactions, with a particular emphasis on the life sciences and biotech industries. Ms. Waldron has extensive experience representing clients through all phases of their business cycles and advising them how to best take advantage of varying business opportunities, whether arising in the ordinary course of business or as an extraordinary matter. Her regular practice includes counseling her clients in connection with start-up...

(973) 643-5158